SCHEMBL5505972

SCHEMBL5505972

COc1cc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1OCCCNC(=NC#N)N(C)C

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.56
ERBB2 P04626 8/20 0.56
LCK P06239 1/20 0.53
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2736370 1.00 EGFR (0.56) EGFRERBB2LCKHDAC3HDAC4
SCHEMBL2736391 0.93 EGFR (0.52) EGFRERBB2LCKHDAC3HDAC4
SCHEMBL5498832 0.93 EGFR (0.52) EGFRERBB2LCKHDAC3HDAC4
SCHEMBL2760199 0.92 EGFR (0.68) EGFRERBB2
SCHEMBL13946642 0.86 EGFR (0.62) EGFRERBB2
SCHEMBL216073 0.85 EGFR (0.56) EGFRERBB2LCKHDAC3HDAC4
SCHEMBL214931 0.83 EGFR (0.52) EGFRERBB2LCKHDAC3HDAC4
SCHEMBL8305182 0.82 EGFR (0.80) EGFRERBB2LCK
SCHEMBL216038 0.82 EGFR (0.59) EGFRERBB2LCKHDAC3HDAC4
SCHEMBL217990 0.82 EGFR (0.68) EGFRERBB2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567506-A4 CYANOGUANIDINES AND CYANOAMIDINES AS ERBB2 AND EGFR INHIBITORS ARRAY BIOPHARMA INC (US) 2007-06-20 EP disclosed
EP-1567506-A2 CYANOGUANIDINES AND CYANOAMIDINES AS ERBB2 AND EGFR INHIBITORS Array Biopharma, Inc. (US) 2005-08-31 EP disclosed
WO-2004046101-A2 CYANOGUANIDINES AND CYANOAMIDINES AS ERBB2 AND EGFR INHIBITORS ARRAY BIOPHARMA, INC. (US) 2004-06-03 WO disclosed